Olmesartan Medoxomil recalls
Olmesartan Medoxomil products have been recalled 2 times, most recently on 2 Jun 2021. The recalling company is usually Ascend Laboratories.
Total recalls2since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why olmesartan medoxomil is recalled
Companies
Product types
By year
All olmesartan medoxomil recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Olmesartan Medoxomil Tablets, USP, 20 mg recalled by Ascend LaboratoriesOlmesartan Medoxomil | Ascend Laboratories | Other | Nationwide |
| Drug | CLASS II | Olmesartan Medoxomil Tablets 20 mg recalled by Ascend LaboratoriesOlmesartan Medoxomil | Ascend Laboratories | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.